Evommune, Inc. (EVMN) Net margin 2024–2025
Evommune, Inc. (EVMN) net profit margin by fiscal year — reported net income divided by reported revenue.
-529.8%FY2025 · since FY2024: -954.4% → -529.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -529.8% | +424.6 pp |
| FY2024 | -954.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More EVMN financial trends
EVMN RevenueEVMN Net incomeEVMN Gross profitEVMN Gross marginEVMN Operating incomeEVMN Operating marginEVMN Operating cash flowEVMN Free cash flowEVMN Capital expendituresEVMN Return on equityEVMN Stock buybacksEVMN Dividends paidEVMN Total assetsEVMN Total liabilitiesEVMN Shareholders’ equityEVMN overview →